Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Purvish Parikh

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
South Asian Journal of Cancer|January 24, 2014
Importance of dose intensity in treatment of advanced non-small cell lung cancer in the elderlyNarayanan Prasad, Ashish Bakshi, Chetan Deshmukh, et al.
Indian Journal of Pediatrics|February 3, 2005
Metastatic gastric adenocarcinomaR Bhagwat, G Biswas, A Khadwal, et al.
The Medical Journal of Australia|January 22, 2008
Mediastinal lymphadenopathy in a patient with previously treated T-cell acute lymphoblastic leukaemiaNarayan Karanth, Kumar P Prabhash, Pranjali N Karanth, et al.
Frontiers in Nutrition|October 10, 2022
Communication in non-communicable diseases (NCDs) and role of immunomodulatory nutraceuticals in their managementAbhiram Kumar, Kalyani Sakhare, Dwaipayan Bhattacharya, et al.
Molecular Cancer|February 22, 2023
Lung cancer immunotherapy: progress, pitfalls, and promisesAritraa Lahiri, Avik Maji, Pravin D Potdar, et al.
Cancer Causes & Control : CCC|November 10, 2007
Spectrum of HIV/AIDS related cancers in IndiaAruna Alahari Dhir, Sheela Sawant, Rajesh P Dikshit, et al.
South Asian Journal of Cancer|May 4, 2018
Practical consensus recommendations regarding role of mastectomy in metastatic breast cancerS P Somsekhar, K Geeta, R Jain, et al.
Lancet (London, England)|November 1, 2005
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)Nick Thatcher, Alex Chang, Purvish Parikh, et al.
Pediatric Hematology and Oncology|August 30, 2008
RUNX1 aberrations in ETV6/RUNX1-positive and ETV6/RUNX1-negative patients: its hemato-pathological and prognostic significance in a large cohort (619 cases) of ALLAnurita Peter Pais, Pratibha S Amare Kadam, Gauri Chandrakant Raje, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL studyAlex Chang, Purvish Parikh, Sumitra Thongprasert, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
South Asian Journal of Cancer|January 24, 2014
Importance of dose intensity in treatment of advanced non-small cell lung cancer in the elderlyNarayanan Prasad, Ashish Bakshi, Chetan Deshmukh, et al.
Indian Journal of Pediatrics|February 3, 2005
Metastatic gastric adenocarcinomaR Bhagwat, G Biswas, A Khadwal, et al.
The Medical Journal of Australia|January 22, 2008
Mediastinal lymphadenopathy in a patient with previously treated T-cell acute lymphoblastic leukaemiaNarayan Karanth, Kumar P Prabhash, Pranjali N Karanth, et al.
Frontiers in Nutrition|October 10, 2022
Communication in non-communicable diseases (NCDs) and role of immunomodulatory nutraceuticals in their managementAbhiram Kumar, Kalyani Sakhare, Dwaipayan Bhattacharya, et al.
Molecular Cancer|February 22, 2023
Lung cancer immunotherapy: progress, pitfalls, and promisesAritraa Lahiri, Avik Maji, Pravin D Potdar, et al.
Cancer Causes & Control : CCC|November 10, 2007
Spectrum of HIV/AIDS related cancers in IndiaAruna Alahari Dhir, Sheela Sawant, Rajesh P Dikshit, et al.
South Asian Journal of Cancer|May 4, 2018
Practical consensus recommendations regarding role of mastectomy in metastatic breast cancerS P Somsekhar, K Geeta, R Jain, et al.
Lancet (London, England)|November 1, 2005
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)Nick Thatcher, Alex Chang, Purvish Parikh, et al.
Pediatric Hematology and Oncology|August 30, 2008
RUNX1 aberrations in ETV6/RUNX1-positive and ETV6/RUNX1-negative patients: its hemato-pathological and prognostic significance in a large cohort (619 cases) of ALLAnurita Peter Pais, Pratibha S Amare Kadam, Gauri Chandrakant Raje, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL studyAlex Chang, Purvish Parikh, Sumitra Thongprasert, et al.
Pageof 4